HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Zhang Selected Research

Stents

1/2022[Short-term efficacy and perioperative safety of catheter-based intervention for pulmonary vein stenosis caused by fibrosing mediastinitis].
3/2021[Evaluation of the single stage treatment of intracranial or extracranial artery stenosis combined with intracranial aneurysm:experience from a single center].
3/2021[Evaluation of intravascular therapy for cerebral ischemic tandem stenosis].
2/2020[Association between plasma HDL-C levels and coronary artery severity and impact on outcomes of patients underwent percutaneous coronary intervention].
1/2020Incidence and Risk Factors of In-Stent Restenosis for Symptomatic Intracranial Atherosclerotic Stenosis: A Systematic Review and Meta-Analysis.
12/2019[The predictive value of epicardial adipose tissue and inflammatory factors for in-stent restenosis].
11/2019Hemodynamic Analysis of Postoperative Rupture of Unruptured Intracranial Aneurysms after Placement of Flow-Diverting Stents: A Matched Case-Control Study.
2/2019[Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
12/2018[Clinical outcomes with beta-blockers in stable patients undergoing percutaneous coronary intervention with adequate left ventricular ejection function].
11/2018[Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Zhang Research Topics

Disease

409Neoplasms (Cancer)
05/2024 - 01/2000
119Infections
05/2024 - 02/2000
83Inflammation (Inflammations)
04/2024 - 04/2000
80Breast Neoplasms (Breast Cancer)
05/2024 - 01/2000
78Neoplasm Metastasis (Metastasis)
03/2024 - 01/2000
50Fibrosis (Cirrhosis)
04/2024 - 03/2001
47Carcinogenesis
11/2021 - 06/2000
46Hypertension (High Blood Pressure)
01/2023 - 04/2000
45Body Weight (Weight, Body)
04/2024 - 11/2000
45Hepatocellular Carcinoma (Hepatoma)
09/2023 - 06/2000
44Pain (Aches)
03/2024 - 08/2000
43Carcinoma (Carcinomatosis)
11/2023 - 01/2000
43Hypoxia (Hypoxemia)
01/2021 - 04/2000
42Wounds and Injuries (Trauma)
05/2024 - 06/2000
39Necrosis
12/2022 - 12/2000
38Hemorrhage
12/2023 - 01/2000
37Stomach Neoplasms (Stomach Cancer)
02/2024 - 07/2001
36Obesity
04/2024 - 10/2000
35Lung Neoplasms (Lung Cancer)
01/2023 - 12/2000
32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 06/2001
32Myocardial Infarction
03/2023 - 04/2000
31Ischemia
08/2023 - 06/2000
30Prostatic Neoplasms (Prostate Cancer)
04/2024 - 03/2000
30Stroke (Strokes)
01/2023 - 05/2000
29Insulin Resistance
01/2024 - 06/2005
28Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 07/2001
28Thrombosis (Thrombus)
10/2023 - 11/2000
26Type 2 Diabetes Mellitus (MODY)
12/2022 - 09/2000
25Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2021 - 06/2000
24Leukemia
05/2024 - 01/2001
23Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 07/2000
22Reperfusion Injury
08/2021 - 06/2000
21Osteoarthritis
05/2024 - 02/2007
21Asthma (Bronchial Asthma)
05/2022 - 07/2000
20Pre-Eclampsia (Preeclampsia)
03/2024 - 05/2000
20Ovarian Neoplasms (Ovarian Cancer)
08/2023 - 01/2000
20Pneumonia (Pneumonitis)
06/2023 - 08/2000
20Alzheimer Disease (Alzheimer's Disease)
01/2017 - 11/2000
19Rheumatoid Arthritis
04/2024 - 10/2000
19Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2024 - 03/2012
18Heart Failure
04/2023 - 04/2000
18Tuberculosis (Tuberculoses)
09/2018 - 03/2000
17Infarction (Infarctions)
06/2019 - 02/2000
17Hypersensitivity (Allergy)
01/2019 - 06/2000
16Parkinson Disease (Parkinson's Disease)
04/2024 - 11/2000
16Lymphatic Metastasis
02/2023 - 09/2006
16Disease Progression
05/2022 - 11/2001
16Lymphoma (Lymphomas)
04/2022 - 01/2001
16Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 11/2001
15Proteinuria
03/2024 - 01/2000
15Atherosclerosis
01/2023 - 06/2001
15Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 04/2005

Drug/Important Bio-Agent (IBA)

234Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2000
104Messenger RNA (mRNA)IBA
01/2024 - 01/2000
66CytokinesIBA
07/2022 - 02/2000
61MicroRNAs (MicroRNA)IBA
05/2024 - 03/2009
57Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2004
56Glucose (Dextrose)FDA LinkGeneric
02/2024 - 02/2000
49Long Noncoding RNAIBA
05/2024 - 03/2014
39DNA (Deoxyribonucleic Acid)IBA
06/2023 - 01/2000
34Insulin (Novolin)FDA Link
01/2023 - 02/2000
33RNA (Ribonucleic Acid)IBA
04/2024 - 01/2000
33Therapeutic UsesIBA
03/2024 - 03/2001
32Interleukin-6 (Interleukin 6)IBA
03/2024 - 11/2001
32EnzymesIBA
11/2021 - 12/2000
31AntigensIBA
03/2024 - 03/2000
30VaccinesIBA
07/2023 - 04/2001
28Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2001
27LipidsIBA
04/2024 - 04/2000
26Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 12/2000
26CollagenIBA
12/2023 - 01/2000
23Phosphotransferases (Kinase)IBA
11/2022 - 10/2000
21C-Reactive ProteinIBA
04/2024 - 11/2006
21Hormones (Hormone)IBA
04/2024 - 04/2000
21Immunoglobulin G (IgG)IBA
12/2023 - 01/2000
21Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2000
20salicylhydroxamic acid (SHAM)IBA
06/2022 - 04/2000
20Small Interfering RNA (siRNA)IBA
03/2022 - 01/2004
18CholesterolIBA
03/2024 - 03/2000
18Indicators and Reagents (Reagents)IBA
02/2024 - 03/2000
18AntibodiesIBA
10/2023 - 04/2001
18LigandsIBA
08/2021 - 02/2000
18Cisplatin (Platino)FDA LinkGeneric
02/2021 - 06/2001
17NF-kappa B (NF-kB)IBA
04/2023 - 05/2000
17Peptides (Polypeptides)IBA
07/2020 - 10/2000
16Oxygen (Dioxygen)IBA
02/2024 - 03/2000
16ErbB Receptors (EGF Receptor)IBA
09/2023 - 01/2000
16LipopolysaccharidesIBA
06/2023 - 04/2009
16Anti-Bacterial Agents (Antibiotics)IBA
04/2023 - 09/2000
15AutoantibodiesIBA
12/2022 - 01/2000

Therapy/Procedure

194Therapeutics
03/2024 - 03/2000
75Drug Therapy (Chemotherapy)
03/2024 - 01/2000
36Radiotherapy
03/2024 - 01/2000
32Aftercare (After-Treatment)
11/2023 - 01/2000
27Transplantation
09/2023 - 08/2000
25Stents
01/2022 - 04/2001
21Hematopoietic Stem Cell Transplantation
03/2023 - 08/2005
20Immunotherapy
09/2023 - 02/2001
19Percutaneous Coronary Intervention
05/2022 - 05/2015
17Ligation
02/2023 - 04/2000